Sex- and region-specific associations of skeletal muscle mass with metabolic dysfunction-associated fatty liver disease

Fatty Liver Index and Skeletal Muscle Density

(2022) Julie A. Pasco et al.   CALCIFIED TISSUE INTERNATIONAL

Myosteatosis, but not Sarcopenia, Predisposes NAFLD Subjects to Early Steatohepatitis and Fibrosis Progression

(2022) Yun-Cheng Hsieh et al.   Clinical Gastroenterology and Hepatology

Associations of muscle mass and grip strength with severe NAFLD: a prospective study of 333,295 UK Biobank participants

(2022) Fanny Petermann-Rocha et al.   JOURNAL OF HEPATOLOGY

Association of Muscle Strength with Non-Alcoholic Fatty Liver Disease in Korean Adults

(2022) Sung-Bum Lee et al.   International Journal of Environmental Research and Public Health

Reference values of skeletal muscle area for diagnosis of sarcopenia using chest computed tomography in Asian general population

(2022) Sung Woo Moon et al.   Journal of Cachexia Sarcopenia and Muscle

Sex-related association of nonalcoholic fatty liver disease and liver fibrosis with body fat distribution in the general US population

(2022) Stefano Ciardullo et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

Microbiota analysis and transient elastography reveal new extra-hepatic components of liver steatosis and fibrosis in obese patients

(2021) Nicolas Lanthier et al.   Scientific Reports

Prevalence of NAFLD, MAFLD and associated advanced fibrosis in the contemporary United States population

(2021) Stefano Ciardullo et al.   LIVER INTERNATIONAL

Tobacco Smoke and CYP1A2 Activity in a US Population with Normal Liver Enzyme Levels

(2021) Alexis Garduno et al.   International Journal of Environmental Research and Public Health

Sex influences the association between appendicular skeletal muscle mass to visceral fat area ratio and non-alcoholic steatohepatitis in patients with biopsy-proven non-alcoholic fatty liver disease

(2021) Gang Li et al.   BRITISH JOURNAL OF NUTRITION

Low skeletal muscle mass is associated with liver fibrosis in individuals with type 2 diabetes and nonalcoholic fatty liver disease

(2021) Mohammad Shafi Kuchay et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Impedance-based measures of muscle mass can be used to predict severity of hepatic steatosis in pediatric NAFLD

(2021) Toshifumi Yodoshi et al.   NUTRITION

Computed Tomography-Derived Myosteatosis and Metabolic Disorders

(2021) Iva Miljkovic et al.   Diabetes & Metabolism Journal

Association of Skeletal Muscle and Adipose Tissue Distribution with Histologic Severity of Non-Alcoholic Fatty Liver

(2021) Min-Kyu Kang et al.   Diagnostics

Physical activity and diet quality in relation to non-alcoholic fatty liver disease: A cross-sectional study in a representative sample of U.S. adults using NHANES 2017–2018.

(2021) Natalia I. Heredia et al.   PREVENTIVE MEDICINE

Prevalence of steatosis and fibrosis in young adults in the UK: a population-based study

(2020) Kushala W M Abeysekera et al.   Lancet Gastroenterology & Hepatology

A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement

(2020) Mohammed Eslam et al.   JOURNAL OF HEPATOLOGY

Association between muscle strength and advanced fibrosis in non‐alcoholic fatty liver disease: a Korean nationwide survey

(2020) Sunyoung Kang et al.   Journal of Cachexia Sarcopenia and Muscle

MAFLD vs. NAFLD: shared features and potential changes in epidemiology, pathophysiology, diagnosis, and pharmacotherapy

(2020) Ying-Xin Xian et al.   CHINESE MEDICAL JOURNAL

Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

(2019) Peter J. Eddowes et al.   GASTROENTEROLOGY

Body mass index and body composition in relation to 14 cardiovascular conditions in UK Biobank: a Mendelian randomization study

(2019) Susanna C Larsson et al.   EUROPEAN HEART JOURNAL

The relationship between non-alcoholic fatty liver and skeletal muscle mass to visceral fat area ratio in women with type 2 diabetes

(2019) Xiaoyou Su et al.   BMC Endocrine Disorders

Associations Between Measures of Sarcopenic Obesity and Risk of Cardiovascular Disease and Mortality: A Cohort Study and Mendelian Randomization Analysis Using the UK Biobank

(2019) Ruth E. Farmer et al.   Journal of the American Heart Association

Sarcopenia and fatty liver disease

(2019) Jung A. Kim et al.   Hepatology International

Vibration-controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease

(2018) Mohammad S. Siddiqui et al.   Clinical Gastroenterology and Hepatology

Sarcopenia in Patients with Advanced Liver Disease

(2018) Francesca Romana Ponziani et al.   CURRENT PROTEIN & PEPTIDE SCIENCE

Trunk muscle quality assessed by computed tomography: Association with adiposity indices and glucose tolerance in men

(2018) Alexandre Maltais et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Evaluation of the Healthy Eating Index-2015

(2018) Jill Reedy et al.   Journal of the Academy of Nutrition and Dietetics

Sarcopenia in hiding: The risk and consequence of underestimating muscle dysfunction in nonalcoholic steatohepatitis

(2017) Rahima A. Bhanji et al.   HEPATOLOGY

Nonalcoholic fatty liver disease and sarcopenia in a Western population (NHANES III): The importance of sarcopenia definition

(2017) Tao-Chun Peng et al.   CLINICAL NUTRITION

Mitochondrial dynamics, quality control and miRNA regulation in skeletal muscle: implications for obesity and related metabolic disease

(2016) D. Dahlmans et al.   CLINICAL SCIENCE

Gender Differences in Skeletal Muscle Substrate Metabolism – Molecular Mechanisms and Insulin Sensitivity

(2014) Anne-Marie Lundsgaard et al.   Frontiers in Endocrinology

Intramuscular Fat and Associations With Metabolic Risk Factors in the Framingham Heart Study

(2013) Kate E. Therkelsen et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Epidemiology of myosteatosis

(2010) Iva Miljkovic et al.   CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE